Stratasys Completes U.S. Rollout of 3D-Printed Imaging Support Material

Yahoo Finance 2 min read Beginner
Stratasys has finished the nationwide rollout in the United States of its 3D-printed imaging support material, making the product broadly available to healthcare providers and industrial customers. The material is positioned to help users manage complex geometries and optimize workflows where imaging and post-processing are essential — for example, in preoperative planning models, diagnostic mock-ups, and precision manufacturing checks.

According to Stratasys, the new support material integrates with its existing additive manufacturing ecosystem, enabling smoother printing cycles and simplified removal processes. That integration aims to reduce manual finish work, lower turnaround times and help produce parts that are better suited for subsequent imaging steps such as CT or MRI visualization and quality-inspection scans.

The rollout follows pilot deployments and collaborative testing with early adopters across clinical and manufacturing settings. Early users reported improved consistency in printed parts and fewer artifacts during imaging, which can translate into more reliable diagnostics and improved confidence in inspection outcomes. By standardizing support structures for complex prints, the material also seeks to reduce scrap and rework, contributing to cost efficiencies.

Stratasys has made the material available through its dealer network and direct channels across the U.S., accompanied by technical guidance and recommended print settings to help customers adopt it quickly. The company emphasizes compatibility with a range of its printers and recommends validation steps tailored to customer-specific applications.

While the announcement focuses on U.S. availability, Stratasys continues to explore broader distribution and application development. For hospitals, clinics and manufacturers evaluating additive solutions that intersect with medical imaging or high-precision inspection, the material offers an option aimed at improving downstream imaging clarity and operational throughput. Market observers will watch how adoption scales across medical and industrial segments and whether the material drives measurable improvements in production efficiency and imaging reliability.